Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392,193,323
-
Total 13F shares
-
102,947,641
-
Share change
-
+1,144,371
-
Total reported value
-
$5,908,051,029
-
Put/Call ratio
-
52%
-
Price per share
-
$57.39
-
Number of holders
-
267
-
Value change
-
+$82,535,646
-
Number of buys
-
119
-
Number of sells
-
166
Institutional Holders of DEXCOM INC - Common Stock (DXCM) as of Q4 2017
As of 31 Dec 2017,
DEXCOM INC - Common Stock (DXCM) was held by
267 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
102,947,641 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, FMR LLC, BAILLIE GIFFORD & CO, MORGAN STANLEY, BlackRock Inc., BROWN ADVISORY INC, and Capital World Investors.
This page lists
267
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.